1. Home
  2. MRVI vs VCV Comparison

MRVI vs VCV Comparison

Compare MRVI & VCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • VCV
  • Stock Information
  • Founded
  • MRVI 2014
  • VCV 1993
  • Country
  • MRVI United States
  • VCV United States
  • Employees
  • MRVI N/A
  • VCV N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • VCV Trusts Except Educational Religious and Charitable
  • Sector
  • MRVI Health Care
  • VCV Finance
  • Exchange
  • MRVI Nasdaq
  • VCV Nasdaq
  • Market Cap
  • MRVI 449.6M
  • VCV 530.6M
  • IPO Year
  • MRVI 2020
  • VCV N/A
  • Fundamental
  • Price
  • MRVI $3.69
  • VCV $10.80
  • Analyst Decision
  • MRVI Buy
  • VCV
  • Analyst Count
  • MRVI 7
  • VCV 0
  • Target Price
  • MRVI $4.54
  • VCV N/A
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • VCV 107.9K
  • Earning Date
  • MRVI 11-06-2025
  • VCV 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • VCV 4.09%
  • EPS Growth
  • MRVI N/A
  • VCV N/A
  • EPS
  • MRVI N/A
  • VCV 0.13
  • Revenue
  • MRVI $192,435,000.00
  • VCV N/A
  • Revenue This Year
  • MRVI N/A
  • VCV N/A
  • Revenue Next Year
  • MRVI $7.27
  • VCV N/A
  • P/E Ratio
  • MRVI N/A
  • VCV $75.82
  • Revenue Growth
  • MRVI N/A
  • VCV N/A
  • 52 Week Low
  • MRVI $1.67
  • VCV $8.05
  • 52 Week High
  • MRVI $6.21
  • VCV $10.40
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 61.21
  • VCV 38.28
  • Support Level
  • MRVI $3.37
  • VCV $10.70
  • Resistance Level
  • MRVI $3.76
  • VCV $11.38
  • Average True Range (ATR)
  • MRVI 0.25
  • VCV 0.14
  • MACD
  • MRVI 0.05
  • VCV -0.08
  • Stochastic Oscillator
  • MRVI 91.63
  • VCV 14.68

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About VCV Invesco California Value Municipal Income Trust

Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.

Share on Social Networks: